| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.004 | 0.9 |